Atara Biotherapeutics Inc. (NASDAQ: ATRA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ATARA BIOTHERAPEUTICS INC.

Atara Biotherapeutics Inc. (NASDAQ: ATRA)
Listen to this Section


$9.96
-0.3150 ( -3.07% ) 23.1K

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Clinical Trial Pipeline Stages


Drug Name Stage
ATA188DetailsEpstein-Barr virus, Multiple sclerosis Phase 2
ATA3219DetailsSystemic lupus erythematosus, Lupus nephritis, Autoimmune disease Phase 1
ATA3219DetailsNon-Hodgkin lymphoma, Blood cancer, Cancer Phase 1
ATA188DetailsMultiple sclerosis, Epstein-Barr virus Failed

Market Data


Open $9.96
Previous Close $10.27
Volume 23.1K
Market Cap $86.77M
Day Range $9.84 - $10.47
52 Week Range $3.92 - $19.15
Shares Outstanding 9.01M
Change % -3.07%
Net Change ▼ -0.3150
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
IPO Year2014
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -3,685,812.00

Date Type Amount Purchased Purchaser
2025-08-19 Buy 55000.00 Panacea Innovation Ltd
2025-07-21 Buy 19335.00 Panacea Innovation Ltd
2024-08-14 Sale -9000.00 Touchon Pascal
2024-05-20 Sale -81506.00 Touchon Pascal
2024-05-20 Sale -25750.00 Henrich Jill
2024-05-20 Sale -28648.00 Hyllengren Eric J
2024-05-20 Sale -32401.00 Murugan Amar
2024-05-20 Sale -42899.00 Nguyen AnhCo
2024-04-02 Sale -150000.00 Gallagher Carol Giltner
2024-04-02 Sale -150000.00 Roncarolo Maria Grazia

SEC Filings


Form Type Description Pages Date
schedule Other 1 Aug 19, 2025
4 Insider transactions 1 Aug 19, 2025
10-q Quarterly Reports 76 Aug 11, 2025
8-k 8K-related 11 Aug 11, 2025
4 Insider transactions 1 Jul 21, 2025
8-k 8K-related 13 Jul 14, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy